A 52-year-old man with metastatic pancreatic adenocarcinoma presents with acute dyspnea, chest pain, and hemoptysis. On examination, he is hypotensive (BP 88/54), tachycardic (HR 118), and has cyanosis. Chest X-ray shows bilateral pulmonary infiltrates. Laboratory findings: Hb 8.5 g/dL with schistocytes on smear, platelet count 32,000/µL, PT 22 s (control 12 s), aPTT 52 s (control 28 s), fibrinogen 110 mg/dL, D-dimer 12 µg/mL. Arterial blood gas shows PaO₂ 58 mmHg on room air. What is the primary mechanism of organ dysfunction in this patient?

Question

Accepted Answer

A. Fibrin deposition in pulmonary microvasculature leading to acute respiratory distress and microangiopathic hemolysis. ## DIC-Induced Multi-Organ Failure in Metastatic Cancer

### Clinical Recognition of DIC with Organ Involvement

**Key Point:** This patient has **overt DIC with acute respiratory distress syndrome (ARDS)** secondary to metastatic pancreatic cancer. The primary pathophysiology is **microthrombi formation in the pulmonary circulation**, not mechanical obstruction or cardiac failure.

### Laboratory Evidence of DIC

| Parameter | Finding | Interpretation |
|-----------|---------|----------------|
| Platelets | 32,000/µL | Consumption |
| PT/aPTT | 22 s / 52 s | Factor consumption |
| Fibrinogen | 110 mg/dL | Consumption + fibrinolysis |
| D-dimer | 12 µg/mL | Fibrin formation & degradation |
| Schistocytes | Present | Mechanical hemolysis from fibrin strands |
| PaO₂ | 58 mmHg | Pulmonary dysfunction |

**High-Yield:** Pancreatic cancer is one of the **top 3 solid tumors** causing DIC (along with lung and gastric cancers). Cancer cells express tissue factor (TF) on their surface, directly activating the extrinsic coagulation pathway.

### Mechanism of Pulmonary Involvement in DIC

```mermaid
flowchart TD
  A[Pancreatic cancer cells]:::outcome --> B[Express Tissue Factor]:::action
  B --> C[Extrinsic pathway activation]:::action
  C --> D[Thrombin generation]:::outcome
  D --> E[Fibrin deposition in lungs]:::urgent
  E --> F[Microthrombi in pulmonary capillaries]:::urgent
  F --> G[Ventilation-Perfusion mismatch]:::action
  F --> H[Capillary injury & increased permeability]:::action
  G --> I[Hypoxemia]:::urgent
  H --> J[Pulmonary edema & ARDS]:::urgent
  D --> K[RBC fragmentation on fibrin strands]:::action
  K --> L[Schistocytes & hemolysis]:::outcome
```

**Clinical Pearl:** The combination of **schistocytes + thrombocytopenia + respiratory failure + coagulopathy** in a cancer patient is DIC until proven otherwise. The hemolysis is **mechanical** (RBCs passing through fibrin-lined capillaries), not immune-mediated.

### Why This Is DIC, Not Other Diagnoses

**Mnemonic:** **CANCER-DIC** — Consumption of platelets, Abnormal PT/aPTT, Necrosis of tissues (microthrombi), Coagulation activation, Elevated D-dimer, Respiratory distress, Disseminated fibrin deposition, Ischemia of organs, Consumption of fibrinogen.

### Pathophysiology of Pulmonary ARDS in DIC

1. **Microthrombi formation** in pulmonary capillaries → mechanical obstruction of blood flow
2. **Endothelial injury** from thrombin and fibrin deposition → increased vascular permeability
3. **Platelet and leukocyte sequestration** in lungs → inflammatory cytokine release (IL-6, TNF-α, IL-8)
4. **Surfactant dysfunction** from inflammatory mediators → alveolar collapse
5. **Result:** Severe hypoxemia (PaO₂ 58 mmHg), bilateral infiltrates, and shock

**Warning:** Do NOT confuse DIC-induced ARDS with sepsis-induced ARDS. In sepsis, fibrinogen is typically **elevated** (acute phase reactant), whereas in DIC it is **consumed and low**. This patient's fibrinogen of 110 mg/dL confirms consumption, not inflammation alone.

### Management Priorities

1. **Treat the underlying cancer:** Chemotherapy (gemcitabine-based regimen for pancreatic cancer)
2. **Supportive care:** Mechanical ventilation, ICU monitoring
3. **Coagulation support:** FFP + cryoprecipitate for factor/fibrinogen replacement (target fibrinogen >100 mg/dL)
4. **Anticoagulation:** Low-dose unfractionated heparin (controversial but may reduce microthrombi formation) — use cautiously given active bleeding risk
5. **Avoid:** Platelet transfusions unless active bleeding and platelets <10,000/µL

**High-Yield:** The prognosis of DIC in solid tumors is poor; mortality is 40–80% despite treatment. Early recognition and aggressive management of the underlying malignancy offer the only chance of DIC reversal.

[cite:Robbins 10e Ch 13; Harrison 21e Ch 180]

![DIC diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/2682.webp)

Answer

B. Sepsis-induced endotoxemia with capillary leak syndrome

Answer

C. Acute left ventricular failure secondary to myocardial infarction

Answer

D. Direct tumor invasion of the pulmonary vasculature with mechanical obstruction

Explanation

DIC-Induced Multi-Organ Failure in Metastatic Cancer

Clinical Recognition of DIC with Organ Involvement

Laboratory Evidence of DIC

Mechanism of Pulmonary Involvement in DIC

Why This Is DIC, Not Other Diagnoses

Pathophysiology of Pulmonary ARDS in DIC

Management Priorities

Practice similar questions

Join our NEET PG community

Parameter	Finding	Interpretation
Platelets	32,000/µL	Consumption
PT/aPTT	22 s / 52 s	Factor consumption
Fibrinogen	110 mg/dL	Consumption + fibrinolysis
D-dimer	12 µg/mL	Fibrin formation & degradation
Schistocytes	Present	Mechanical hemolysis from fibrin strands
PaO₂	58 mmHg	Pulmonary dysfunction